GORTEC Groupe d'Oncologie Radiothérapie Tête Et Cou
Gortec_logo
  • Home
  • Gortec
    • Presentation
    • Mission
  • Professionals
    • Generalities
    • Next meeting
    • Gortec Journal
  • Publications
    • GORTEC
    • Meta-analysis publications
  • Clinical Trials
    • Ongoing Clinical Trials
    • Pending publications
    • Completed and published
  • Links
  • Français (France)
  • English (UK)

 

 

Our mission

OUR MISSION

Coordinate clinical and/or laboratory studies.

Publications

PUBLICATIONS

GORTEC publications.

Trials

Trials

Find all trials.

Chairman’s message

Sample author Jean Bourhis Oncology and Radiotherapy CHUV

Dear colleagues and friends,

We are all working together - at GORTEC, Unicancer, GETTEC, GERCOR and now REFCOR - to develop a truly remarkable shared momentum to support clinical research and optimize the treatment of head and neck cancers. Our clinical trials stand out within the global panorama in terms of both number and quality. A significant proportion of our research concerns trials without links to the pharmaceutical industry (Cisfrad, Saltorl, Santal, etc.) and we are also at the forefront when it comes to asking major questions - via the TPextreme trial, for example - and incorporating the latest developments in the field of immunotherapy (REACH, PembroRad, TopNivo, Nivo post-op, Rewrite, Frail-immune etc.).

We owe our success to the invaluable contributions made by each and every one of you and by each investigator site, and also to the support and motivation of our operational teams, to whom I wish to extend my warmest thanks.

Gortec's Industrial Partners

	Astra Zeneca
Merck MSD
Merck Group
Bristol Myers Squibb

Trials Newsletters

Last Newsletters available online

StereoPostOp

Sample image

Newsletter StereoPostOp

Pembrorad

Sample image

Newsletter Pembrorad

Elan

Sample image

Newsletter Elan

TPExtreme

Sample image

Newsletter TPExtreme

REACH

Sample image

Newsletter REACH

SANTAL

Sample image

Newsletter SANTAL

SALTORL

Sample image

Newsletter SALTORL

OMET

Sample image

Newsletter OMET

REWRITe

Sample image

Newsletter REWRITe

SIMPA01

Sample image

Newsletter SIMPA01

NIVOPOST-OP

Sample image

Newsletter NIVOPOST-OP

GORTEC

CHRU DE TOURS
Hôpital Bretonneau BAT 47
2 Bd Tonnellé
37044 Tours cedex 9

Téléphone : +33 2 47 31 01 85
Télécopie : +33 2 47 77 05 48
Email : contact@gortec.fr

REJOIGNEZ-NOUS SUR
  • Gortec
  • Site map
  • Search on website
Copyright © 2019 GORTEC - Groupe d'Oncologie Radiothérapie Tête Et Cou
By using our website, you agree to the use of cookies to ensure you get the best experience on our website.
Read more